drag_handle
DxMedical Cloud™
Technology for overwhelmingly high-speed detection from all over the world.
We use our unique algorithm to deliver the latest technology and product information from around the world in real time.
Explore the future of healthcare with carefully selected information.
How We Help You To Empower Your Business
POINT 1.
Quickly Deliver Technical Information
We deliver what you seek quickly and in a short time from technical information from all over the world
POINT 2.
Briefly to the Point
A wealth of detailed features makes it easy to understand the main points
POINT 3.
Help with Growth Strategies
The report is also packed with analytical information from the perspective of growth and long-term strategies for business use
Catch Up on the Latest Information
from Around the World
In today's world, where the world is networked by advances in information technology and numerous technologies are evolving at an astonishing speed, it is extremely difficult to manually collect and manage the vast amount of information from all over the world.
DxMedical Cloud™ collects and analyzes professional information from around the world and uses proprietary algorithms to quickly and accurately deliver the information you seek and the best information for you.
search
Quick search in Japanese
You can quickly search for information published in various languages around the world in Japanese. Get the information you need from the vast amount of information available worldwide without having to worry about language barriers.
emergency
Recommendations for You
DxMedical Cloud's proprietary algorithms predict the best information based on your interests and preferences and deliver it to you daily. Stay one step ahead of the curve without the hassle of searching, maximizing your daily information gathering.
Fuzzy Search
In addition to word matching, the search by similar and related keywords delivers news that is often missed due to paraphrasing and shaky spelling.
Japanese Localization
By providing titles and summaries of information from around the world in Japanese, it streamlines the process of “finding” the information you want from search results.
Academic Search
For researchers and professionals, you can search and browse more specialized information, such as articles submitted to journals by universities and research institutes.
More features to enhance your team's productivity
Bookmark
Instantly save and manage information that you like or want to look at later because you don't have time, with the bookmark function. You can access the information you need without hassle, saving you a great deal of time and effort.
Note Editor
Simple and intuitive operation allows you to quickly consolidate all information into a notebook and organize information efficiently. It can be used as a powerful tool for effective information sharing.
Information sharing
A wide range of information sharing tools are available, including chat and note sharing functions. We support information sharing with your team in all situations, from casual information sharing to organizing information in teams.
Collaboration
Provides task management functions specifically designed to make information gathering and sharing more efficient. In addition to regular task management functions, this useful tool supports information gathering and sharing, improving the productivity of the entire team.
DigitalMedical Open Innovation
BrainEnergy produce DigitalMedical open innovation from Tokyo, where you can experience the intersection of cool and passionate design and technology.
Transform Your Business With Cloud
Looking for the Future of Health Care
OUR TECHNOLOGY HELPS YOUR BUSINESS
Our technology will help your business
Technology
Artificial protein sensor: A new method for measuring cortisol using a smartphone
Cortisol is a hormone that regulates important bodily functions such as blood pressure and metabolism, and abnormalities in cortisol levels can have adverse effects on health. Until now, measurement at medical institutions has been the norm, but the development of new artificial biosensors has made high-precision measurement possible at home or in clinics.The sensor developed by Professor Andrew Ye of the University of California, Santa Cruz, uses a smartphone camera to measure light intensity and directly read cortisol levels. This technology employs artificially designed proteins based on computational modeling, offering higher sensitivity and a broader detection range compared to traditional naturally derived proteins. This detection method is also expected to have applications in drug development and diagnostics.
Project uses AI to develop system for monitoring musculoskeletal disease progression
Musculoskeletal disorders such as osteoarthritis, arthritis, and sports injuries affect more than 1.7 billion people worldwide, according to the World Health Organization (WHO). To address this challenge, Blautic Designs, AIMPLAS (Plastics Technology Centre), the European Musculoskeletal Institute (IMSKE), Crespo Printing Group, and the Universitat Politècnica de València (UPV) have launched the KINESSENSOR project. The goal is to develop an innovative AI-powered solution focused on creating a portable system that, through the integration and combined use of printed and conventional sensors, enables the identification, monitoring, and tracking of joint, ligament, or muscle injuries or pain. The project specifically targets a condition known as arthrogenic muscle inhibition (AMI), which causes hypertonia in the hamstring muscles and frequently occurs in anterior cruciate ligament injuries and knee prosthetic surgery. The presence of AMI leads to muscle contractures, increased pain, and rehabilitation difficulties.
Naolys launches ExoCell: custom plant Exosome Biotech
After two years of collaborative research with the University of Bordeaux, Naolys, the French expert in plant cell biotechnology, unveils ExoCell: a breakthrough innovation that enables formulators and brands to customize plant-derived exosomes
Dexcom Launches Revolutionary AI-Powered Meal Logging Feature Across Glucose Biosensing Portfolio
DexCom, Inc., the global leader in glucose biosensing, announced today it has released a new AI-powered photo meal logging feature to Stelo, the first over-the-counter glucose biosensor cleared by the FDA in the United States, following the feature’s launch on Dexcom G7 earlier this year. Dexcom’s Smart Food Logging feature encourages and enables users to log their meals more consistently. Stelo and Dexcom G7 users can now simply take a photo of their food in the app where AI will automatically identify the ingredients and populate the meal description. Dexcom G7 is the only prescription continuous glucose monitor in the U.S. to support photo logging2,3.
New Insights into the Role of “MyTriggerase,” the Key to Rejuvenation—Identifying an Enzyme Essential for Mitochondrial Network Formation After Damage
On June 25, 2025, Taisho Pharmaceutical announced new findings in mitochondrial research. While the company has previously conducted extensive research on aging cells and skin aging, this study revealed that the enzyme “mytrigase,” present within mitochondria, plays a crucial role in forming the mitochondrial network involved in repairing damage to skin cells. Previous research established that diminished mitochondrial function contributes to skin aging. This new study indicates that when the network structure of mitochondria is disrupted by factors like UV radiation or oxidative stress, it undergoes a reformation process during repair. However, it was confirmed that a reduction in mitrigase inhibits this reformation. Furthermore, the company's previous research indicated that mitrigase levels in skin decrease with aging, potentially leading to a decline in DNA damage repair capacity. These new findings, combined with prior insights, strongly support mitrigase as a key factor in suppressing skin aging. Building on its long-established pharmaceutical research foundation, Taisho Pharmaceutical continues to disseminate information pursuing “beauty and health” by applying cutting-edge dermatological science. This achievement announcement is part of that effort. The company plans to accelerate its research focused on mitrigase, intensifying its efforts to address the root causes of skin aging.
Empatica Unveils EmbraceMini: The World’s Smallest Actigraphy Wearable for Clinical Trials
Empatica, a pioneer in digital biomarker development and patient monitoring using wearables and AI, today unveiled EmbraceMini, its revolutionary new wearable for clinical trials. EmbraceMini is an ultra-compact health monitoring device, focused on delivering exceptional wearability and high-quality data without compromising sponsor or participant needs. With its incredibly small footprint and refined looks, EmbraceMini offers effortless, seamless and non-invasive activity data collection while prioritizing the patient experience at all times. It wirelessly transmits sensor data to the FDA-cleared Empatica Health Monitoring Platform, enabling the continuous analysis and extraction of precise digital biomarkers from clinical trial participants while boosting compliance.
PathAI and Moffitt Cancer Center Announce Strategic Collaboration to Deploy the AISight® Dx Digital Pathology Platform and Advance AI Diagnostics
PathAI, a global leader in artificial intelligence and digital pathology solutions, and Moffitt Cancer Center, one of the nation’s top cancer hospitals and a leader in cancer research, today announced a multi-year strategic collaboration to deploy PathAI’s digital pathology platform, AISight® Dx, across Moffitt’s pathology programs to transform cancer detection and innovation. AISight® Dx, is PathAI’s cloud-native digital pathology image management system designed to support both laboratory workflow and translational research use cases. It combines enterprise-scale slide management, viewing, and collaboration with seamless AI integration, driving scalable pathology operational efficiencies and enhanced speed and accuracy. The partnership also establishes a framework for joint research programs, collation of real-world multimodal data, initiatives to support clinical trials and biopharma collaborations, and the co-development of next-generation AI-based diagnostics to enhance precision medicine.
World’s most accurate artificial tongue mimics human taste using graphene and AI
Scientists have built a graphene-based device that can taste with near-human accuracy in a breakthrough that pushes artificial sensing closer to human ability. The system uses machine learning to interpret chemical signals and classify flavors, even those it hasn’t seen before. What sets this invention apart is its ability to work in moist conditions, a first for artificial gustatory systems.
Neuro Flow Labs launches nifty sleep tech neckband on Kickstarter
Hong Kong-founded sleep technology creator Neuro Flow Labs just launched a unique new sleep wearable for insomnia treatment on Kickstarter. The Vyntalix Deep Sleep Neurostimulator works its magic by harnessing cervical transcutaneous vagus nerve stimulation (ct-VNS) — a means of invigorating the vagus nerve with electrodes. This device is relatively novel in comparison to the various sleep tech headbands out there as it is designed to be worn on your neck. However, there is one similar device made by the Lithuanian technology creator Pulsetto, but it is more expensive and doesn’t have one of Vynatlix’s capabilities. Neuro’s device is “complemented by 650-nanometer laser-targeted irradiation of the carotid artery” that promotes metabolism and improves blood microcirculation at the same time, as specified by the company.
Changes in taste perception during category-incongruent taste-olfactory presentations using a breath-synchronized olfactory presentation device
Simultaneous presentation of category-mismatched visual and olfactory information with food changes the perceived flavor, but the effect of category-mismatched taste-olfactory information on the per- ceived flavor remains unclear. In this study, fish odor was presented during the ingestion of beef jerky using the Breath-Synchronized Olfactory Display, and the effects of category-mismatched taste and olfac- tory stimuli on perceived flavor were evaluated. As a result, the sensation of beef jerky was reduced with the breath-linking olfactory fish odor stimuli, and the sensation of dried squid was strongly perceived. The results suggest that the integrating category-mismatched taste and olfactory information changes the cate- gorical perception of flavor.
Australian start-up raises funds to commercialize lactoferrin, one of the world's rarest and most promising compounds
Brisbane-based biotech startup Eclipse Ingredients has emerged from stealth with more than $7 million in funding to commercialise one of the world’s most elusive and promising compounds: lactoferrin. The raise includes $2.9 million in funding from the Commonwealth Government’s Food and Beverage Accelerator (FaBA), alongside investment from AgFunder.
Engineering ATP Synthase with Enhanced Energy Transduction Beyond Natural Limits: Toward Applications in Cellular Engineering and Bio-manufacturing
A research team led by Lecturer Hiroshi Ueno and Professor Hiroyuki Noji from the Graduate School of Engineering, the University of Tokyo, in collaboration with Professor Takeshi Murata from the Graduate School of Science, Chiba University, and Professor Toshiya Senda and Associate Professor Naruhiko Adachi (currently Associate Professor at the Life Science Center for Survival Dynamics, Tsukuba Advanced Research Alliance (TARA), University of Tsukuba) from the Institute of Materials Structure Science, High Energy Accelerator Research Organization (KEK), has successfully engineered an ATP synthase—an enzyme responsible for producing ATP, a universal energy carrier essential for all living organisms—with an energy transduction capability surpassing that of any naturally occurring counterpart reported to date. The redesigned ATP synthase was shown to synthesize ATP even under extremely low proton motive force—a condition in which natural enzymes typically fail to function. This breakthrough was achieved by introducing a novel molecular design: increasing the number of proton channels in the enzyme from one to as many as three. This is the first report worldwide to realize such a design. The study provides a new perspective on the mechanisms of bioenergetic conversion and lays a foundation for future applications in cellular engineering and bio-manufacturing.
MantaBio Prepping Molecular Test System to Curtail Cell Culture Contamination for Biopharma
Manta Bio aims to address the unmet needs of biopharmaceutical developers for contamination detection. The company has raised $2.5 million in seed funding to support its research and development. MantaVision can handle sample sizes ranging from 1 milliliter to 10 milliliters.
DxMedical Cloud™
Technology for overwhelmingly high-speed detection from all over the world.
We use our unique algorithm to deliver the latest technology and product information from around the world in real time.
Explore the future of healthcare with carefully selected information.
How We Help You To Empower Your Business
POINT 1.
Quickly Deliver Technical Information
We deliver what you seek quickly and in a short time from technical information from all over the world
POINT 2.
Briefly to the Point
A wealth of detailed features makes it easy to understand the main points
POINT 3.
Help with Growth Strategies
The report is also packed with analytical information from the perspective of growth and long-term strategies for business use
DigitalMedical Open Innovation
デジタル・メディカル・オープンイノベーション
BrainEnergy produce DigitalMedical open innovation from Tokyo, where you can experience the intersection of cool and passionate design and technology.
Transform Your Business With Cloud
Looking for the Future
of Health Care
OUR TECHNOLOGY HELPS
YOUR BUSINESS
Our technology will help your business
Technology
Artificial protein sensor: A new method for measuring cortisol using a smartphone
Cortisol is a hormone that regulates important bodily functions such as blood pressure and metabolism, and abnormalities in cortisol levels can have adverse effects on health. Until now, measurement at medical institutions has been the norm, but the development of new artificial biosensors has made high-precision measurement possible at home or in clinics.The sensor developed by Professor Andrew Ye of the University of California, Santa Cruz, uses a smartphone camera to measure light intensity and directly read cortisol levels. This technology employs artificially designed proteins based on computational modeling, offering higher sensitivity and a broader detection range compared to traditional naturally derived proteins. This detection method is also expected to have applications in drug development and diagnostics.
ma-clinique.fr
Project uses AI to develop system for monitoring musculoskeletal disease progression
Musculoskeletal disorders such as osteoarthritis, arthritis, and sports injuries affect more than 1.7 billion people worldwide, according to the World Health Organization (WHO). To address this challenge, Blautic Designs, AIMPLAS (Plastics Technology Centre), the European Musculoskeletal Institute (IMSKE), Crespo Printing Group, and the Universitat Politècnica de València (UPV) have launched the KINESSENSOR project. The goal is to develop an innovative AI-powered solution focused on creating a portable system that, through the integration and combined use of printed and conventional sensors, enables the identification, monitoring, and tracking of joint, ligament, or muscle injuries or pain. The project specifically targets a condition known as arthrogenic muscle inhibition (AMI), which causes hypertonia in the hamstring muscles and frequently occurs in anterior cruciate ligament injuries and knee prosthetic surgery. The presence of AMI leads to muscle contractures, increased pain, and rehabilitation difficulties.
Medtech Insigts
Naolys launches ExoCell: custom plant Exosome Biotech
After two years of collaborative research with the University of Bordeaux, Naolys, the French expert in plant cell biotechnology, unveils ExoCell: a breakthrough innovation that enables formulators and brands to customize plant-derived exosomes
Cosmetics Business
Dexcom Launches Revolutionary AI-Powered Meal Logging Feature Across Glucose Biosensing Portfolio
DexCom, Inc., the global leader in glucose biosensing, announced today it has released a new AI-powered photo meal logging feature to Stelo, the first over-the-counter glucose biosensor cleared by the FDA in the United States, following the feature’s launch on Dexcom G7 earlier this year. Dexcom’s Smart Food Logging feature encourages and enables users to log their meals more consistently. Stelo and Dexcom G7 users can now simply take a photo of their food in the app where AI will automatically identify the ingredients and populate the meal description. Dexcom G7 is the only prescription continuous glucose monitor in the U.S. to support photo logging2,3.
businesswire
New Insights into the Role of “MyTriggerase,” the Key to Rejuvenation—Identifying an Enzyme Essential for Mitochondrial Network Formation After Damage
On June 25, 2025, Taisho Pharmaceutical announced new findings in mitochondrial research. While the company has previously conducted extensive research on aging cells and skin aging, this study revealed that the enzyme “mytrigase,” present within mitochondria, plays a crucial role in forming the mitochondrial network involved in repairing damage to skin cells. Previous research established that diminished mitochondrial function contributes to skin aging. This new study indicates that when the network structure of mitochondria is disrupted by factors like UV radiation or oxidative stress, it undergoes a reformation process during repair. However, it was confirmed that a reduction in mitrigase inhibits this reformation. Furthermore, the company's previous research indicated that mitrigase levels in skin decrease with aging, potentially leading to a decline in DNA damage repair capacity. These new findings, combined with prior insights, strongly support mitrigase as a key factor in suppressing skin aging. Building on its long-established pharmaceutical research foundation, Taisho Pharmaceutical continues to disseminate information pursuing “beauty and health” by applying cutting-edge dermatological science. This achievement announcement is part of that effort. The company plans to accelerate its research focused on mitrigase, intensifying its efforts to address the root causes of skin aging.
DxMedical Cloud™︎
Empatica Unveils EmbraceMini: The World’s Smallest Actigraphy Wearable for Clinical Trials
Empatica, a pioneer in digital biomarker development and patient monitoring using wearables and AI, today unveiled EmbraceMini, its revolutionary new wearable for clinical trials. EmbraceMini is an ultra-compact health monitoring device, focused on delivering exceptional wearability and high-quality data without compromising sponsor or participant needs. With its incredibly small footprint and refined looks, EmbraceMini offers effortless, seamless and non-invasive activity data collection while prioritizing the patient experience at all times. It wirelessly transmits sensor data to the FDA-cleared Empatica Health Monitoring Platform, enabling the continuous analysis and extraction of precise digital biomarkers from clinical trial participants while boosting compliance.
Businesswire
PathAI and Moffitt Cancer Center Announce Strategic Collaboration to Deploy the AISight® Dx Digital Pathology Platform and Advance AI Diagnostics
PathAI, a global leader in artificial intelligence and digital pathology solutions, and Moffitt Cancer Center, one of the nation’s top cancer hospitals and a leader in cancer research, today announced a multi-year strategic collaboration to deploy PathAI’s digital pathology platform, AISight® Dx, across Moffitt’s pathology programs to transform cancer detection and innovation. AISight® Dx, is PathAI’s cloud-native digital pathology image management system designed to support both laboratory workflow and translational research use cases. It combines enterprise-scale slide management, viewing, and collaboration with seamless AI integration, driving scalable pathology operational efficiencies and enhanced speed and accuracy. The partnership also establishes a framework for joint research programs, collation of real-world multimodal data, initiatives to support clinical trials and biopharma collaborations, and the co-development of next-generation AI-based diagnostics to enhance precision medicine.
Business Insider
World’s most accurate artificial tongue mimics human taste using graphene and AI
Scientists have built a graphene-based device that can taste with near-human accuracy in a breakthrough that pushes artificial sensing closer to human ability. The system uses machine learning to interpret chemical signals and classify flavors, even those it hasn’t seen before. What sets this invention apart is its ability to work in moist conditions, a first for artificial gustatory systems.
Interesting Engineering
Neuro Flow Labs launches nifty sleep tech neckband on Kickstarter
Hong Kong-founded sleep technology creator Neuro Flow Labs just launched a unique new sleep wearable for insomnia treatment on Kickstarter. The Vyntalix Deep Sleep Neurostimulator works its magic by harnessing cervical transcutaneous vagus nerve stimulation (ct-VNS) — a means of invigorating the vagus nerve with electrodes. This device is relatively novel in comparison to the various sleep tech headbands out there as it is designed to be worn on your neck. However, there is one similar device made by the Lithuanian technology creator Pulsetto, but it is more expensive and doesn’t have one of Vynatlix’s capabilities. Neuro’s device is “complemented by 650-nanometer laser-targeted irradiation of the carotid artery” that promotes metabolism and improves blood microcirculation at the same time, as specified by the company.
Mugglehead Magazine
Changes in taste perception during category-incongruent taste-olfactory presentations using a breath-synchronized olfactory presentation device
Simultaneous presentation of category-mismatched visual and olfactory information with food changes the perceived flavor, but the effect of category-mismatched taste-olfactory information on the per- ceived flavor remains unclear. In this study, fish odor was presented during the ingestion of beef jerky using the Breath-Synchronized Olfactory Display, and the effects of category-mismatched taste and olfac- tory stimuli on perceived flavor were evaluated. As a result, the sensation of beef jerky was reduced with the breath-linking olfactory fish odor stimuli, and the sensation of dried squid was strongly perceived. The results suggest that the integrating category-mismatched taste and olfactory information changes the cate- gorical perception of flavor.
jstage.jst.go.jp
Australian start-up raises funds to commercialize lactoferrin, one of the world's rarest and most promising compounds
Brisbane-based biotech startup Eclipse Ingredients has emerged from stealth with more than $7 million in funding to commercialise one of the world’s most elusive and promising compounds: lactoferrin. The raise includes $2.9 million in funding from the Commonwealth Government’s Food and Beverage Accelerator (FaBA), alongside investment from AgFunder.
SmartCompany
Engineering ATP Synthase with Enhanced Energy Transduction Beyond Natural Limits: Toward Applications in Cellular Engineering and Bio-manufacturing
A research team led by Lecturer Hiroshi Ueno and Professor Hiroyuki Noji from the Graduate School of Engineering, the University of Tokyo, in collaboration with Professor Takeshi Murata from the Graduate School of Science, Chiba University, and Professor Toshiya Senda and Associate Professor Naruhiko Adachi (currently Associate Professor at the Life Science Center for Survival Dynamics, Tsukuba Advanced Research Alliance (TARA), University of Tsukuba) from the Institute of Materials Structure Science, High Energy Accelerator Research Organization (KEK), has successfully engineered an ATP synthase—an enzyme responsible for producing ATP, a universal energy carrier essential for all living organisms—with an energy transduction capability surpassing that of any naturally occurring counterpart reported to date. The redesigned ATP synthase was shown to synthesize ATP even under extremely low proton motive force—a condition in which natural enzymes typically fail to function. This breakthrough was achieved by introducing a novel molecular design: increasing the number of proton channels in the enzyme from one to as many as three. This is the first report worldwide to realize such a design. The study provides a new perspective on the mechanisms of bioenergetic conversion and lays a foundation for future applications in cellular engineering and bio-manufacturing.
UTOKYO School of Engineering
MantaBio Prepping Molecular Test System to Curtail Cell Culture Contamination for Biopharma
Manta Bio aims to address the unmet needs of biopharmaceutical developers for contamination detection. The company has raised $2.5 million in seed funding to support its research and development. MantaVision can handle sample sizes ranging from 1 milliliter to 10 milliliters.
GenomeWeb